{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:53:51Z","timestamp":1787871231201,"version":"build-2784847793"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0228917","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T13:48:10Z","timestamp":1581601690000},"page":"e0228917","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Using old antibiotics to treat ancient bacterium\u2014\u03b2-lactams for Bacillus anthracis meningitis"],"prefix":"10.1371","volume":"15","author":[{"given":"Assa","family":"Sittner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ben-Shmuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itai","family":"Glinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Bar-David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Schlomovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kobiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shay","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1902-8535","authenticated-orcid":true,"given":"Haim","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"issue":"11","key":"pone.0228917.ref001","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"TC Dixon","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"pone.0228917.ref002","first-page":"13","article-title":"Anthrax pathogenesis and host response","volume":"225","author":"P Hanna","year":"1998","journal-title":"Curr Top Microbiol Immunol"},{"issue":"22","key":"pone.0228917.ref003","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMra012892","article-title":"Recognition and management of anthrax\u2014an update","volume":"345","author":"MN Swartz","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"pone.0228917.ref004","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jiph.2010.07.004","article-title":"A review of cutaneous anthrax and its outcome","volume":"3","author":"M Doganay","year":"2010","journal-title":"Journal of Infection and Public Health"},{"issue":"7","key":"pone.0228917.ref005","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3201\/eid0807.020062","article-title":"Anthrax of the gastrointestinal tract","volume":"8","author":"T Sirisanthana","year":"2002","journal-title":"Emerging infectious diseases"},{"key":"pone.0228917.ref006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1749-6632.1980.tb18910.x","article-title":"Inhalation Anthrax","volume":"353","author":"PC Brachman","year":"1980","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"3","key":"pone.0228917.ref007","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/08998280.2005.11928074","article-title":"Anthrax: a continuing concern in the era of bioterrorism","volume":"18","author":"S Riedel","year":"2005","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"6","key":"pone.0228917.ref008","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1073\/pnas.90.6.2291","article-title":"Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979","volume":"90","author":"FA Abramova","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"pone.0228917.ref009","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/modpathol.3880337","article-title":"Quantitative pathology of inhalational anthrax I: quantitative microscopic findings","volume":"14","author":"LM Grinberg","year":"2001","journal-title":"Mod Pathol"},{"issue":"5","key":"pone.0228917.ref010","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/0300985810378112","article-title":"Pathology of inhalational anthrax animal models","volume":"47","author":"NA Twenhafel","year":"2010","journal-title":"Vet Pathol"},{"issue":"10","key":"pone.0228917.ref011","doi-asserted-by":"crossref","first-page":"e0186613","DOI":"10.1371\/journal.pone.0186613","article-title":"Pathology of wild-type and toxin-independent Bacillus anthracis meningitis in rabbits","volume":"12","author":"A Sittner","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"pone.0228917.ref012","doi-asserted-by":"crossref","first-page":"e112319","DOI":"10.1371\/journal.pone.0112319","article-title":"The central nervous system as target of Bacillus anthracis toxin independent virulence in rabbits and guinea pigs","volume":"9","author":"H Levy","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"pone.0228917.ref013","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10120506","article-title":"Infection with a Nonencapsulated Bacillus anthracis Strain in Rabbits-The Role of Bacterial Adhesion and the Potential for a Safe Live Attenuated Vaccine","volume":"10","author":"I Glinert","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"4","key":"pone.0228917.ref014","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00000441-194810000-00006","article-title":"Anthrax; 36 human cases of the external type treated successfully with penicillin","volume":"216","author":"BA La","year":"1948","journal-title":"Am J Med Sci"},{"issue":"11","key":"pone.0228917.ref015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJM195103152441102","article-title":"Newer antibiotics in the treatment of anthrax","volume":"244","author":"H Gold","year":"1951","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0228917.ref016","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/pds.1086","article-title":"Lessons learned from the CDC's post-exposure prophylaxis program following the anthrax attacks of 2001","volume":"14","author":"EA Bresnitz","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"pone.0228917.ref017","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"JA Jernigan","year":"2001","journal-title":"Emerging infectious diseases"},{"issue":"2","key":"pone.0228917.ref018","doi-asserted-by":"crossref","DOI":"10.3201\/eid2002.130687","article-title":"Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults","volume":"20","author":"KA Hendricks","year":"2014","journal-title":"Emerging infectious diseases"},{"issue":"4","key":"pone.0228917.ref019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6404a1","article-title":"Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident","volume":"64","author":"WA Bower","year":"2015","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"pone.0228917.ref020","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40262-017-0601-x","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones","volume":"57","author":"C Roger","year":"2018","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"pone.0228917.ref021","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00298-18","article-title":"Treating Anthrax-Induced Meningitis in Rabbits","volume":"62","author":"A Ben-Shmuel","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"pone.0228917.ref022","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.mam.2009.08.005","article-title":"The genome and variation of Bacillus anthracis","volume":"30","author":"P Keim","year":"2009","journal-title":"Mol Aspects Med"},{"issue":"8","key":"pone.0228917.ref023","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1128\/JCM.42.8.3626-3634.2004","article-title":"MICs of Selected Antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a Range of Clinical and Environmental Sources as Determined by the Etest","volume":"42","author":"PCB Turnbull","year":"2004","journal-title":"Journal of Clinical Microbiology"},{"issue":"7","key":"pone.0228917.ref024","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1128\/AAC.46.7.2307-2309.2002","article-title":"Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000","volume":"46","author":"JD Cavallo","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"pone.0228917.ref025","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1128\/IAI.00244-12","article-title":"Differential Contribution of Bacillus anthracis Toxins to Pathogenicity in Two Animal Models","volume":"80","author":"H Levy","year":"2012","journal-title":"Infect Immun"},{"key":"pone.0228917.ref026","volume-title":"Molecular cloining a laboratory manual","author":"J Sambrook","year":"1989"},{"issue":"23\u201324","key":"pone.0228917.ref027","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin","volume":"19","author":"PF Fellows","year":"2001","journal-title":"Vaccine"},{"issue":"7226","key":"pone.0228917.ref028","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature07591","article-title":"Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis","volume":"457","author":"JV Kim","year":"2009","journal-title":"Nature"},{"issue":"9","key":"pone.0228917.ref029","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1128\/JVI.03149-13","article-title":"Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines\/cytokines induced by rabies virus infection","volume":"88","author":"Q Chai","year":"2014","journal-title":"J Virol"},{"key":"pone.0228917.ref030","unstructured":"WHO. Anthrax in humans and animals: World Health Organization; 2008. Available from: http:\/\/www.who.int\/csr\/resources\/publications\/anthrax_webs.pdf."},{"issue":"2","key":"pone.0228917.ref031","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/bsp.2007.0066","article-title":"Inhalation anthrax: dose response and risk analysis","volume":"6","author":"ME Coleman","year":"2008","journal-title":"Biosecur Bioterror"},{"issue":"3","key":"pone.0228917.ref032","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1128\/JB.185.3.823-830.2003","article-title":"Beta-lactamase genes of the penicillin-susceptible Bacillus anthracis Sterne strain","volume":"185","author":"Y Chen","year":"2003","journal-title":"J Bacteriol"},{"issue":"5","key":"pone.0228917.ref033","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00003495-198122050-00001","article-title":"Amoxycillin\/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use","volume":"22","author":"RN Brogden","year":"1981","journal-title":"Drugs"},{"issue":"5","key":"pone.0228917.ref034","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1128\/AAC.02139-13","article-title":"Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants","volume":"58","author":"M Cohen-Wolkowiez","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0228917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T13:48:28Z","timestamp":1581601708000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0228917"}},"subtitle":[],"editor":[{"given":"Haroon","family":"Mohammad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0228917","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,13]]}}}